Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125384082 | 12538408 | 2 | F | 20101229 | 20160819 | 20160707 | 20160824 | EXP | PHHO2010TW19816 | NOVARTIS | 50.53 | YR | F | Y | 59.00000 | KG | 20160824 | MD | TW | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125384082 | 12538408 | 1 | PS | NVP-AHU377,VALSARTAN | SACUBITRILVALSARTAN | 1 | Oral | 400 MG, QD | 5600 | MG | Y | 207620 | 400 | MG | TABLET | QD | |||
125384082 | 12538408 | 2 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | U | 0 | ||||||||||
125384082 | 12538408 | 3 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Unknown | U | 0 | ||||||||||
125384082 | 12538408 | 4 | C | DEXOFEN | 2 | Unknown | U | 0 | |||||||||||
125384082 | 12538408 | 5 | C | KALIMATE | CALCIUM POLYSTYRENE SULFONATE | 1 | Unknown | U | 0 | ||||||||||
125384082 | 12538408 | 6 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125384082 | 12538408 | 1 | Essential hypertension |
125384082 | 12538408 | 2 | Product used for unknown indication |
125384082 | 12538408 | 3 | Product used for unknown indication |
125384082 | 12538408 | 4 | Product used for unknown indication |
125384082 | 12538408 | 5 | Product used for unknown indication |
125384082 | 12538408 | 6 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125384082 | 12538408 | OT |
125384082 | 12538408 | HO |
125384082 | 12538408 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125384082 | 12538408 | Acute kidney injury | |
125384082 | 12538408 | Base excess decreased | |
125384082 | 12538408 | Blood creatine phosphokinase increased | |
125384082 | 12538408 | Blood lactate dehydrogenase increased | |
125384082 | 12538408 | Dysarthria | |
125384082 | 12538408 | Eosinophilia | |
125384082 | 12538408 | Escherichia infection | |
125384082 | 12538408 | Fungal infection | |
125384082 | 12538408 | Gait disturbance | |
125384082 | 12538408 | Hepatic function abnormal | |
125384082 | 12538408 | Hepatic necrosis | |
125384082 | 12538408 | Hepatitis acute | |
125384082 | 12538408 | Infection | |
125384082 | 12538408 | Leukocytosis | |
125384082 | 12538408 | Microcytic anaemia | |
125384082 | 12538408 | Pulmonary oedema | |
125384082 | 12538408 | Renal impairment | |
125384082 | 12538408 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125384082 | 12538408 | 1 | 20101216 | 20101229 | 0 |